Evidence map›Paper›PMID 30367867›Full record

ReviewInternational journal for parasitology2019

Investigating disease severity in an animal model of concurrent babesiosis and Lyme disease.

Purnima Bhanot, Nikhat Parveen

Open access · greenAbstract readReview
In one paragraph

Review in International journal for parasitology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
2.5field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 32 citations in OpenAlex.

  1. Review
  2. Immunity beyond borders: non-lethalFrontiers in immunology · 2026
    Article
  3. Article
  4. Beyond Human Babesiosis: Prevalence and Association ofOpen forum infectious diseases · 2024
    Article
  5. Review
  6. Article
  7. Coinfection ofPathogens (Basel, Switzerland) · 2024
    Review
  8. Impact ofFrontiers in immunology · 2024
    Article
  9. Review
  10. Article
  11. Tick-borne diseases in Egypt: A one health perspective.One health (Amsterdam, Netherlands) · 2022
    Review
  12. Review
  13. Human Co-Infections betweenPathogens (Basel, Switzerland) · 2022
    Review
  14. Occurrence and Identification ofPathogens (Basel, Switzerland) · 2021
    Article
  15. Review
  16. Article
  17. Frontiers in cellular and infection microbiology · 2020
    Article
  18. Article
  19. Article
  20. A lethal combination: fulminant liver failure due toTherapeutic advances in infectious disease
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Purnima BhanotDepartment of Microbiology, Biochemistry and Molecular Genetics, Rutgers New Jersey Medical School, Newark, NJ, USA.
Nikhat ParveenDepartment of Microbiology, Biochemistry and Molecular Genetics, Rutgers New Jersey Medical School, Newark, NJ, USA. Electronic address: Parveeni@njms.rutgers.edu.
Rutgers, The State University of New Jersey · US

Funding

Borrelia burgdorferi-glycosaminoglycan interactions and Lyme disease pathogenesisR01AI089921 · NIAID · UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL · PI PARVEEN, NIKHAT · 2011 to 2015
$1.7M
NIAID NIH HHS R01 AI089921
6 · The paper itself

Abstract

The incidence of babesiosis, Lyme disease and other tick-borne diseases has increased steadily in Europe and North America during the last five decades. Babesia microti is transmitted by species of Ixodes, the same ticks that transmit the Lyme disease-causing spirochete, Borrelia burgdorferi. B. microti can also be transmitted through transfusion of blood products and is the most common transfusion-transmitted infection in the U.S.A. Ixodes ticks are commonly infected with both B. microti and B. burgdorferi, and are competent vectors for transmitting them together into hosts. Few studies have examined the effects of coinfections on humans and they had somewhat contradictory results. One study linked coinfection with B. microti to a greater number of symptoms of overall disease in patients, while another report indicated that B. burgdorferi infection either did not affect babesiosis symptoms or decreased its severity. Mouse models of infection that manifest pathological effects similar to those observed in human babesiosis and Lyme disease offer a unique opportunity to thoroughly investigate the effects of coinfection on the host. Lyme disease has been studied using the susceptible C3H mouse infection model, which can also be used to examine B. microti infection to understand pathological mechanisms of human diseases, both during a single infection and during coinfections. We observed that high B. microti parasitaemia leads to low haemoglobin levels in infected mice, reflecting the anaemia observed in human babesiosis. Similar to humans, B. microti coinfection appears to enhance the severity of Lyme disease-like symptoms in mice. Coinfected mice have lower peak B. microti parasitaemia compared to mice infected with B. microti alone, which may reflect attenuation of babesiosis symptoms reported in some human coinfections. These findings suggest that B. burgdorferi coinfection attenuates parasite growth while B. microti presence exacerbates Lyme disease-like symptoms in mice.

Indexed as

AnimalsBabesia microtiBabesiosisBorrelia burgdorferiCoinfectionDisease Models, AnimalLyme DiseaseMice, Inbred C3HBabesia microtiBabesiosisBorrelia burgdorferiCoinfectionsTick-borne diseases

Identifiers

PMID30367867
PMCPMC6399035
OpenAlexW2898342607

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.